HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels.

AuthorsHubert Marotte, Eric Fakra, René-Marc Flipo, Thierry Schaeverbeke, Marmar Kabir-Ahmadi, Laure Gossec, Florence E Lévy-Weil
JournalJoint bone spine (Joint Bone Spine) Vol. 89 Issue 5 Pg. 105425 (10 2022) ISSN: 1778-7254 [Electronic] France
PMID35716881 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • sarilumab
  • Methotrexate
Topics
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Arthritis, Rheumatoid (chemically induced, drug therapy)
  • Cognition
  • Humans
  • Methotrexate (therapeutic use)
  • Patient Reported Outcome Measures
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: